vaccine sales. The vaccine market could account for more than 25 billion by 2012. If we look at the top 5 pharmaceutical companies, vaccine sales represent between 8 to 9% of their total sales. The top 20 vaccines brands account for 80% of total vaccine sales. Large companies have recently attempted to acquire market share. In 2005, Novartis bought Chiron's remaining 58% for $5.1 billion (now making 100%). "Vaccines continue to emerge as significant value drivers for major pharma. A promising alternative to conventional vaccines, DNA vaccines, is under late clinical phase development" comments Philippe Tramoy, managing partner.
Key players: Sanofi-Aventis, Sanofi-Pasteur, GSK, Wyeth, Merck, Norvartis, Chiron, Avax Technologies, CSL Biotherapies, Omrix biopharmaceuticals, Epimmune, Oxxon Therapeutics, Vical, Fit Biotech, Genencor, Innogenetics.
If you need market and business intelligence service in the vaccine market, please contact us at contact @ cbdmt.com.
CBDM.T® - Market and Business Intelligence- is a market and business intelligence company with offices in France, Switzerland and Israel. As an advisory services company, CBDM.T® boosts companies to develop revenue and growth by providing business and marketing services in the life science and biotech markets (market surveys, market scouting, business development and strategic supports).
For more information:
CBDM.T® Market and Business Intelligence
88-90 rue de la Mare
Fr-75020 Paris - France
Tel : +33 1 4474 7957
Email: contact @ cbdmt.com
Web site: CBDM.T®
CBDM.T® - Israel
Netanya - 42490 - Israel
Tel: +972 52 3316190
Page: 1 2 3 Related biology technology :1
Copyright©2009 Vocus, Inc.
All rights reserved
. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market 2
. CBDM.T, the Market and Business Intelligence Company Reviews the Biofuel Market3
. CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market4
. CBDM.T, The Market and Business Intelligence Company Reviews The Enzyme Market 5
. Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market6
. Sinobiopharma, Inc. Appoints New Director of Marketing7
. Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market8
. Beacon Equity Issues Trade Alerts on Market Movers: CAH, LEAP, FISV, PBG, ARNA, LEN9
. Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications10
. VisualSonics to Sell Mauna Kea Technologies Cellvizio(R) LAB on a Worldwide Basis to Animal Imaging Market11
. BioMedical Enterprises, Inc. (BME) Announces the Appointment of Keith M. Peeples as Vice President, Sales and Marketing